TG Therapeutics (TGTX) stock spikes as Roche (RHHBY) fails in a Phase 3 trial for a high dose version of its multiple ...
Advanced Micro Devices, Inc. faces challenges in the slowing AI market, with Nvidia's dominance and custom chips reshaping ...
CoreWeave’s 2022 to 2024 financial path is one of hypergrowth, efficiency improvement, and early-stage profitability. In 2022 ...
Exxon Mobil's stock remains steady year-over-year. Learn why the recent price rise may not last and explore its long-term ...
BB Seguridade Participações S.A. offers a 9% dividend yield but is overvalued. Click for my look at BBSEY stock and its big ...
Will tariffs cause inflation and higher interest rates? Jitania Kandhari discusses how subsidies, sanctions & security ...
Overall, the fourth quarter of 2024 was characterized by resilient labor market dynamics, strong economic growth and sticky ...
EU antitrust authorities are expected to approve Safran's (OTCPK:SAFRY) $1.8 billion purchase of Collins Aerospace's flight controls unit. The news comes after the U.K.'s antitrust watchdog on Friday ...
Nebius's diversified revenue streams, lack of debt, and positioning in Europe make it a clear buy over CoreWeave. Learn more about NBIS stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results